Drug Information

Drug General Information
Drug ID
D0DK9S
Former ID
DNC005219
Drug Name
2-(3-Butoxy-4-hydroxy-phenyl)-benzooxazol-6-ol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527232]
Structure
Download
2D MOL

3D MOL
Formula
C17H17NO4
Canonical SMILES
CCCCOC1=CC(=C2NC3=C(O2)C=C(C=C3)O)C=CC1=O
InChI
1S/C17H17NO4/c1-2-3-8-21-16-9-11(4-7-14(16)20)17-18-13-6-5-12(19)10-15(13)22-17/h4-7,9-10,18-19H,2-3,8H2,1H3/b17-11+
InChIKey
NZVGGWFTLGSIOU-GZTJUZNOSA-N
PubChem Compound ID
11415327
Target and Pathway
Target(s) Estrogen receptor Target Info Inhibitor [527232]
Estrogen receptor beta Target Info Inhibitor [527232]
KEGG Pathway Estrogen signaling pathway
Prolactin signaling pathway
Thyroid hormone signaling pathway
Endocrine and other factor-regulated calcium reabsorption
Proteoglycans in cancerhsa04915:Estrogen signaling pathway
NetPath Pathway FSH Signaling Pathway
EGFR1 Signaling Pathway
RANKL Signaling Pathway
Pathway Interaction Database Regulation of nuclear SMAD2/3 signaling
Signaling events mediated by HDAC Class II
Plasma membrane estrogen receptor signaling
LKB1 signaling events
Regulation of Telomerase
ATF-2 transcription factor network
AP-1 transcription factor network
FOXM1 transcription factor network
Validated nuclear estrogen receptor alpha network
Signaling mediated by p38-alpha and p38-beta
FOXA1 transcription factor networker_nongenomic_pathway:Plasma membrane estrogen receptor signaling
Validated nuclear estrogen receptor beta network
Reactome Nuclear signaling by ERBB4
Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway
WikiPathways Estrogen signaling pathway
Nuclear Receptors Meta-Pathway
Estrogen Receptor Pathway
Signaling by ERBB4
JAK/STAT
Integrated Pancreatic Cancer Pathway
Leptin signaling pathway
miR-targeted genes in muscle cell - TarBase
Integrated Breast Cancer Pathway
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
Ovarian Infertility Genes
Nuclear Receptors
References
Ref 527232J Med Chem. 2004 Oct 7;47(21):5021-40.Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Ref 527232J Med Chem. 2004 Oct 7;47(21):5021-40.Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.